Search
Fluradoline
go.drugbank.com/drugs/DB21333ExperimentalFluradoline is a small molecule drug. The usage of the INN stem '-adol/-adol-' in the name indicates that Fluradoline is a analgesic. Fluradoline has a monoisotopic molecular weight of 301.09 Da.
Pinoxepin
go.drugbank.com/drugs/DB21397ExperimentalPinoxepin is a small molecule drug. The usage of the INN stem '-oxepin' in the name indicates that Pinoxepin is a tricyclic compound. Pinoxepin has a monoisotopic molecular weight of 398.18 Da.
Ruzadolane
go.drugbank.com/drugs/DB21444ExperimentalRuzadolane is a small molecule drug. The usage of the INN stem '-adol/-adol-' in the name indicates that Ruzadolane is a analgesic. Ruzadolane has a monoisotopic molecular weight of 375.13 Da.
Lactobacillus coryniformis K8
go.drugbank.com/drugs/DB15733ExperimentalLactobacillus is a common bacteria found in the gut with Lactobacillus coryniformis K8 being originally isolated from artisan goat cheese.
Synonyms: Lc K8Benmelstobart
go.drugbank.com/drugs/DB17473InvestigationalAPL 502 is a humanised immunoglobulin G1 (IgG1) monoclonal antibody targeting the programmed cell death-1 ligand-1 (PD-L1).
DTx-1252
go.drugbank.com/drugs/DB18086ExperimentalDTx-1252 is a siRNA therapeutic under investigation for the treatment of Charcot-Marie-Tooth Disease type 1A (CMTD1A).[L48096]
CSIC002
go.drugbank.com/drugs/DB18584ExperimentalCSIC002 is a small-molecule Sema-3A inhibitor. It is being investigated for the treatment of anterior ischemic optic neuropathy.
LY-2881835
go.drugbank.com/drugs/DB15046InvestigationalLY-2881835 is under investigation in clinical trial NCT01358981 (A Study of LY2881835 in Healthy People and People With Diabetes).
AK106-001616
go.drugbank.com/drugs/DB16058InvestigationalAK106-001616 is under investigation in clinical trial NCT01285752 (A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA)).
LY-3200882
go.drugbank.com/drugs/DB16064InvestigationalLY-3200882 is under investigation in clinical trial NCT04158700 (A Study of LY3200882 and Pembrolizumab in Participants With Advanced Cancer).